Pivotal Provides Update on Status of CDC Offer


Vancouver, B.C., December 5, 2003 — Pivotal Corporation (NASDAQ:PVTL - News; TSX:PVT - News; "Pivotal") announced today that it has received an extension until 8:00 p.m. (Vancouver time), on Saturday, December 6, 2003 to accept a firm offer from chinadotcom corporation (NASDAQ: CHINA), through its software unit, CDC Software Corporation ("CDC"), to acquire all of the issued and outstanding shares of Pivotal Corporation. This extension has been granted by CDC to permit Pivotal to comply with the logistical aspects of accepting the CDC offer in accordance with the terms of the agreement with the Oak Group.
Pivotal Corporation is the only CRM company that is 100 percent purpose-built to serve the demanding requirements of mid-sized enterprises – a powerful, highly flexible application platform, a complete set of CRM applications, and low-cost, results-producing implementation services. Pivotal delivers software and services that produce meaningful increases in revenues, margins and customer loyalty for companies and business units in the revenue range of $100 million to $3 billion. More than 1,600 companies around the world have licensed Pivotal including: CIBC, Centex Homes, Farm Credit Services of America, HarperCollins Publishers, Hitachi Telecom Inc., Palm, Inc., Pharmacia Corporation, Premera Blue Cross, Royal Bank of Canada, Sharp Electronics Corporation, Southern Company, Vivendi and WebEx Communications.

Pivotal's complete CRM software suite includes a powerful application platform and capabilities in marketing, sales, service, contact centers, partner management and interactive selling. For more information, visit www.pivotal.com.
This press release contains forward-looking statements concerning the pending transaction with chinadotcom and CDC and the date of the initial and final court applications in respect of the pending transaction, the extraordinary meeting of Pivotal’s shareholders to consider the transaction with chinadotcom and CDC and the closing of such transaction. Forward-looking statements are not statements of historical fact, and actual results or events may differ materially from those described in the forward-looking statements, as a result of a variety of risks, uncertainties and other factors, including, without limitation, the risk that CDC may not perform its obligations under any agreement that it has or may in the future have with Pivotal, that conditions to closing of any acquisition agreement may not be satisfied, that one or more third parties may make competing acquisition proposals, commence litigation or take other action to seek to delay or prevent consummation of a transaction, or other events may cause Pivotal’s board to deem it advisable to hold the shareholders meeting at a different time or place than presently anticipated. Pivotal assumes no obligation to update forward-looking statements to reflect future events. Investor and Press Contacts:

Larry Dennedy
(212) 929-5239

Daniel Burch
(212) 929-5748